Description
Izofra Nasal Spray 8000 IU/ml. 15 ml. №1 Vial
Ingredients:
Each ml contains 8000 IU of framycetin sulfate as the active ingredient.
Mechanism of Action:
Framycetin sulfate, the active ingredient in Izofra nasal spray, exerts its antibacterial effects by inhibiting protein synthesis in susceptible bacteria, leading to cell death. This mechanism helps eliminate bacterial infections in the nasal passages.
Pharmacological Properties:
Izofra nasal spray containing framycetin sulfate exhibits broad-spectrum antibacterial activity against various pathogens commonly involved in nasal infections. The formulation allows for efficient drug delivery to the nasal mucosa, ensuring targeted therapeutic effects.
Indications for Use:
Izofra nasal spray is specifically indicated for the treatment of bacterial infections of the nasal passages, including cases of bacterial rhinosinusitis.
Contraindications:
Avoid using Izofra nasal spray if you have a known hypersensitivity to framycetin sulfate or any other components of the product. Consult a healthcare provider for suitable alternative treatments in such cases.
Side Effects:
Common side effects associated with Izofra nasal spray may include local irritation, burning sensation, or dryness in the nasal mucosa. In rare instances, allergic reactions or superinfection may occur. Discontinue use and seek medical advice if any adverse effects persist or worsen.
Usage Instructions:
For adults and children, the typical dosage involves administering 1 spray into each nostril 3-4 times daily or as directed by a healthcare professional. Ensure proper priming of the pump before initial use and follow the instructions for optimal drug delivery.
Benefits Compared to Analogues:
Izofra nasal spray stands out from similar products due to its potent antibacterial activity attributed to framycetin sulfate. The targeted delivery system of the spray enhances its efficacy in treating nasal infections while minimizing systemic side effects.
Suitable Patient Groups:
Izofra nasal spray is generally safe for use in both pediatric and geriatric populations. However, individual dosage adjustments may be necessary based on age, medical history, and overall health status. Consult a healthcare provider for personalized recommendations.
Storage Conditions and Shelf Life:
Store Izofra nasal spray at room temperature away from direct sunlight and moisture. Check the product packaging for specific storage instructions. Ensure proper sealing of the vial after each use. Discard any expired or unused medication responsibly.
Packaging Description:
The product is available in a 15 ml vial with a convenient pump mechanism for easy administration. The packaging is designed to maintain the sterility and integrity of the nasal spray throughout its shelf life.
Clinical Evidence and Proven Effectiveness:
Studies have demonstrated the clinical efficacy of Izofra nasal spray in treating bacterial nasal infections. The formulation with framycetin sulfate has shown significant antibacterial properties, effectively reducing symptoms and promoting recovery in patients with nasal pathologies.
